Skip to content
Clinical Trials – home

CHRU De Nancy

VerifiedinfoResponsive

France Rue Du Morvan, 54500 Vandoeuvre Les Nancy, France

  • 254 trials recruiting
  • Crohn's disease · Colitis ulcerative · Non-small cell lung cancer
  • Adults and children

About Specializations

CHRU De Nancy in Vandoeuvre Les Nancy, France specialises in clinical trials of conditions such as Crohn's disease, Colitis ulcerative, Non-small cell lung cancer, Ischaemic stroke, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The department conducts studies on cardiovascular health, aiming to test new therapies and improve patient outcomes.

  • Acute Coronary Syndrome
  • Acute myocardial infarction
  • Chronic Heart Failure With Reduced Ejection Fraction
  • Uncontrolled Hypertension in chronic kidney disease
  • Pulmonary Arterial Hypertension

Ongoing trials evaluate novel anticoagulants, blood‑pressure optimization strategies, and agents that reduce cardiovascular events and heart‑failure hospitalizations.

Digestive System Diseases & Neoplasms

Research focuses on gastro‑intestinal and liver cancers, exploring innovative treatment combinations to extend survival.

  • Hepatocellular Carcinoma
  • Advanced Hepatocellular Carcinoma
  • Biliary tract carcinoma
  • Colon carcinoma
  • Small bowel adenocarcinoma

Studies assess immunotherapy, targeted agents, and neo‑adjuvant chemotherapy protocols to improve disease‑free survival.

Immune System Diseases

Trials address immune‑mediated and autoimmune disorders, seeking safer, more effective therapeutic options.

  • Ulcerative Colitis
  • Crohn's disease
  • Food allergy
  • Non‑infectious uveitis
  • Binge eating disorder

Research evaluates biologics, oral small‑molecule agents, and dietary interventions to control inflammation and improve quality of life.

Hemic and Lymphatic Diseases

The site investigates blood‑related cancers and bone‑marrow failures, aiming to raise remission rates and long‑term survival.

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Diffuse Large B‑Cell Lymphoma
  • Follicular lymphoma
  • Marginal Zone Lymphoma

Studies compare novel kinase inhibitors, bispecific antibodies, and reduced‑intensity conditioning regimens for stem‑cell transplantation.

Nutritional and Metabolic Diseases

Clinical work targets metabolic liver disease and related metabolic disorders, testing agents that reverse tissue damage.

  • Non‑Alcoholic Steatohepatitis (NASH)
  • Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
  • Fibrosis
  • Diabetes‑related complications

Trials assess drugs that improve liver histology, reduce fibrosis, and enhance overall metabolic health.

Respiratory Tract Diseases

Studies aim to improve outcomes for lung‑related conditions, including rare progressive diseases.

  • Interstitial lung disease
  • Pulmonary arterial hypertension
  • Acute respiratory complications

Investigations include targeted therapies and functional measures such as exercise capacity to assess efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Rue Du Morvan54500 Vandoeuvre Les NancyFrance
Recruiting now
254 trials
Conditions studied
221
Partner status
Verified

More sites in Vandoeuvre Les NancyFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

524 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:FranceFrance
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Mrna-4157
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.